Acadia turnaround still lacks stable leaders
- Acadia is a pure-play behavioral health operator with 277 facilities and over 12,500 beds at year-end 2025.
- The business depends heavily on Medicaid, which supplied 57.7% of 2025 revenue.
- The old bull case is damaged by a leadership vacuum, payer denials and rising legal liability costs.
- A $996.2 million goodwill impairment in 2025 shows how much the legal and liability problem has hurt the story.
- Q1 2026 was mixed: adjusted EBITDA beat guidance, but bad debts and denials worsened again.
- The best upside case is that new facilities ramp, referral sources diversify and cash flow steadies.
A turnaround with weak controls
Acadia owns a large behavioral health network in a market with real need. Mental health and substance use care remain scarce in many places. That gives the company a clear reason to exist, and its scale can help it fill beds, build joint ventures and add treatment sites.
The problem is execution. The former bull case rested on steady leadership and free cash flow. That case is now impaired. The company has had major executive turnover, including the departure of the CEO in January 2026 and the pending departure of CFO Todd Young. That makes the $200 million incremental EBITDA target harder to trust.
The operating picture is not all bad. In Q1 2026, management said facilities opened from 2023 to 2025 overachieved expectations, and adjusted EBITDA of $144.2 million came in $7.2 million above the high end of guidance. Acadia also said its Pennsylvania specialty business partly offset volume losses caused by New York's ban on out-of-state Medicaid care.
The bear case still has sharper teeth. Bad debts and denials got worse in Q1 2026 after management had expected stabilization. Professional and general liability costs helped drive a $996.2 million goodwill impairment in 2025. The main question is whether Acadia can rebuild the executive team, fix collections and keep legal costs from eating the turnaround.
Beds, payers and collections
Acadia makes money by treating patients in behavioral health facilities. Its main service lines are acute inpatient psychiatric hospitals, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. Outpatient programs tied to those facilities are included in those service lines.
The company is paid by Medicaid, commercial insurers, Medicare and patients. In 2025, Medicaid was 57.7% of revenue, commercial payers were 24.6%, Medicare was 14.3% and other payers were 3.4%. That mix matters because Medicaid policy and managed care reviews can change how fast Acadia gets paid, how long patients can stay and how much care gets denied.
The model can work when beds are full, staffing is controlled and claims are collected on time. Acadia added 1,089 beds in 2025 and planned 400 to 600 more in 2026, but new facilities often lose money at first. They need licenses, billing setup, staff and referral flow before they help profits.
Where it breaks is clear. A payer can deny more claims. A state can change Medicaid rules. A new facility can open late or fail to fill. Legal claims can raise insurance costs. Acadia is facing several of those problems at once, so investors need more proof before treating this as a clean recovery.
What Acadia operates
Acute inpatient psychiatric facilities
This is Acadia's largest service line, with 55% of 2025 revenue. These hospitals treat patients who need 24-hour monitoring and crisis stabilization.
Specialty treatment facilities
These facilities made up 17% of 2025 revenue. They focus mostly on substance use and co-occurring mental health disorders, but some Pennsylvania sites were hurt by New York's out-of-state Medicaid policy.
Comprehensive treatment centers
CTCs were 17% of 2025 revenue and focus on medication-assisted treatment for opioid use disorder. Acadia opened 15 CTCs in 2025, making this one of the clearer access-point growth areas.
Residential treatment centers
Residential centers were 11% of 2025 revenue. They treat patients in a less intensive setting than hospitals, often for longer stays.
Existing facility bed additions
Acadia added 311 beds to existing facilities in 2025. These projects can be attractive because the company already has local licenses, staff relationships and referral paths.
Joint ventures and de novo facilities
In 2025, Acadia added 778 beds through one wholly-owned facility and five joint venture facilities. The upside is large, but ramp timing, licenses and billing setup have already caused delays.
Revenue by care type
The mix is from Acadia's 2025 Form 10-K and is based on total revenue by facility or service category. Medicaid is also a major concentration, at 57.7% of 2025 revenue.
What could go wrong
Executive vacuum slows the plan
High impact · High oddsAcadia has had major turnover across the top team, including the CEO, CFO and COO changes disclosed in the 2025 10-K. The pending CFO departure adds risk at the exact time the company needs tighter cash control and better collections. A weak transition could slow the $200 million EBITDA opportunity from newer facilities.
Denials and bad debts keep rising
High impact · High oddsManaged Medicaid plans are using more utilization reviews, which can limit length of stay and raise claim denials. Management said bad debts and denials got worse in Q1 2026 than expected. This can pressure revenue, margins and cash flow even if patient demand stays solid.
Legal and liability costs spread
High impact · Medium oddsAcadia recorded a $996.2 million goodwill impairment in 2025 tied in part to higher professional and general liability costs. Its commercial insurance coverage beginning in September 2025 has less favorable terms, including exclusions for incidents involving sexual molestation or abuse. That means some future claims could land more directly on Acadia.
Medicaid policy cuts into volume
Medium impact · Medium oddsNew York's ban on out-of-state Medicaid care created an estimated $25 million to $30 million annual EBITDA headwind and led Acadia to close two leased specialty facilities in Pennsylvania. Management is finding other referral sources, but state policy can change faster than facilities can adapt. Federal OBBBA eligibility rules are a smaller worry for now because management does not expect a material impact due to exemptions for many of Acadia's patients.
New sites do not ramp fast enough
Medium impact · Medium oddsAcadia added 1,089 beds in 2025 and expected 400 to 600 bed additions in 2026. New facilities can lose money while they wait for licenses, billing setup and enough patient volume. Q1 2026 brought a positive sign because the 2023 to 2025 facility cohort beat expectations, but one quarter is not enough proof.
Debt limits flexibility
Medium impact · Medium oddsAt year-end 2025, Acadia reported a 4.0x consolidated total net leverage ratio under its credit agreement and was in compliance with covenants. The company also issued $550.0 million of 7.375% senior notes due 2033. If earnings fall or legal cash costs rise, debt can make the recovery harder.
In one breath
What does Acadia Healthcare do?
Acadia runs behavioral healthcare facilities in the U.S. Its sites treat psychiatric illness, substance use disorder and higher-acuity behavioral health needs.
Why is Medicaid so important to Acadia?
Medicaid supplied 57.7% of Acadia's 2025 revenue. That makes state policy, Medicaid managed care reviews and eligibility rules important drivers of volume and cash collection.
Why did Acadia record a large impairment in 2025?
Acadia recorded a $996.2 million goodwill impairment in 2025. Management tied the weaker outlook to higher professional and general liability costs, lower future revenue projections and other operating pressures.
What would make the stock story improve?
The story improves if Acadia stabilizes leadership, reduces bad debts and denials, contains legal liability costs and proves newer facilities can ramp profitably. The Q1 2026 facility ramp was a good sign, but the company needs more than one quarter of proof.